EBIT: Income before interest and taxes.
Atossa Genetics Inc. (ATOS) had EBIT of $-9.87M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-9.59M |
|
-- |
|
-- |
|
$9.87M |
|
$-9.87M |
|
$0.28M |
|
$-9.59M |
|
$-9.59M |
|
$-9.59M |
|
$-9.59M |
|
$-9.59M |
|
$-9.59M |
|
|
EBIT |
$-9.87M |
$-9.87M |
|
8.62M |
|
8.62M |
|
$-1.11 |
|
$-1.11 |
|
| Balance Sheet Financials | |
$36.67M |
|
-- |
|
$1.27M |
|
$37.94M |
|
$7.46M |
|
-- |
|
-- |
|
$7.46M |
|
$30.49M |
|
$30.49M |
|
$30.49M |
|
8.61M |
|
| Cash Flow Statement Financials | |
$-9.58M |
|
-- |
|
-- |
|
$41.41M |
|
$31.83M |
|
$-9.58M |
|
$0.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-31.45% |
|
-31.45% |
|
-25.27% |
|
-31.45% |
|
$3.54 |
|
$-1.11 |
|
$-1.11 |
|